Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus

Tissue Antigens

Volumn 53, Issue 6, 1999, Pages 527-533

  Komata, T ^a   Tsuchiya, Naoyuki ^a   Matsushita, M ^a   Hagiwara, K ^a   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Genetics; Polymorphism; Susceptibility; Systemic lupus erythematosus (SLE); Tumor necrosis factor receptor 2 (TNFR2)

Indexed keywords

DNA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 0033065921     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530602.x     Document Type: Article

References (34)

1. Tsao BP. Genetic susceptibility to lupus nephritis. Lupus 1998; 7: 585-90.
2. Hashimoto H, Nishimura Y, Dong RP et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994; 23: 191-6.
3. Slingsby JH, Norsworthy P, Pearce G, et al. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum 1996; 39: 663-70.
4. Salmon JE, Millard S, Schachter LA et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-54.
5. Manger K, Repp R, Spriewald BM et al. Fcγ receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: Association with clinical symptoms. Arthritis Rheum 1998; 41: 1181-9.
6. Song YW, Han CW, Kang SW et al. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 421-6.
7. Smyth LJ, Snowden N, Carthy D, Papasteriades C, Hajeer A, Ollier WE. Fcγ RIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 744-6.
8. Wu J, Edberg JC, Redecha PB et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-70.
9. Koene HR, Kleijer M, Swaak AJG et al. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1813-8.
10. Takeuchi T, Tsuzaka K, Pang M, Amano K, Koide J, Abe T. TCR chain lacking exon 7 in two patients with systemic lupus erythematosus. Int Immunol 1998; 10: 911-21.
11. Mehrian R, Quismorio FP Jr, Strassmann G et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998; 41: 596-602.
12. Moser KI, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A 1998; 95: 14869-74.
13. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 1998; 95: 14875-9.
14. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-92.
15. Elliott MJ, Maini RN, Feldmann M et al. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344: 1125-7.
16. Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-α gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 1996; 156: 3043-50.
17. Santee SM, Owen-Schaub LB. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 1996; 271: 21151-9.
18. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
19. Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Akazawa T, Szathmary EJ, eds. Prehistoric Mongoloid Dispersals. Oxford: Oxford University Press, 1996; 187-97.
20. Hatta Y, Tsuchiya N, Matsushita M et al. Identification of the gene variations in human CD22. Immunogenetics 1999; 49: 280-6.
21. Kawai S, Maekawajiri S, Tokunaga K et al. Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtitre plate hybridization) method. Eur J Immunogenet 1996; 23: 471-86.
22. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
23. Lucas R, Lou J, Morel DR, Ricou B, Suter PM, Grau GE. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol 1997; 61: 551-8.
24. Douni E, Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R J Exp Med 1998; 188: 1343-52.
25. Peschon JJ, Torrance DS, Stocking KL et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998; 160: 943-52.
26. Lin RH, Hwang YW, Yang BC, Lin CS, TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. J Immunol 1997; 158: 598-603.
27. Herbein G, Mahlknecht U, Batliwalla F et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998; 395: 189-94.
28. Vaishnaw AK, McNally JD, Elkon KB, Apoptosis in the rheumatic diseases. Arthritis Rheum 1997; 40: 1917-27.
29. Gabay C, Cakir N, Moral F et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumutol 1997; 24: 303-8.
30. Naismith JH, Sprang SR. Modularity in the TNF-receptor family. Trends Biochem Sci 1998; 23: 74-9.
31. Dembic Z, Loetscher H, Guhler U et al. Two human TNT receptors have similar extracellular, but distinct intracellular, domain sequences Cytokine 1990; 2: 231-7.
32. Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci USA 1990; 87: 6151-5.
33. Smith CA, Davis T, Anderson D et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019-23.
34. Rau H, Donner H, Usadel KH, Badenhoop K. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease. Tissue Antigens 1997; 49: 535-6.